Fitness
Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography – Cardiovascular Diabetology
![Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography – Cardiovascular Diabetology Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography – Cardiovascular Diabetology](https://static-content.springer.com/image/art%3A10.1186%2Fs12933-024-02304-0/MediaObjects/12933_2024_2304_Fig1_HTML.png)
Cheng YJ, Imperatore G, Geiss LS, Saydah SH, Albright AL, Ali MK, et al. Trends and disparities in Cardiovascular Mortality among U.S. adults with and without self-reported diabetes, 1988–2015. Diabetes Care. 2018;41(11):2306–15.
Lan Z, Ding X, Yu Y, Yu L, Yang W, Dai X, Ling R, Wang Y, Yang W, Zhang J. CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients. Cardiovasc Diabetol. 2023;22(1):65.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the primary Prevention of Cardiovascular Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Circulation. 2019;140(11):e563–95.
Koh N, Ference BA, Nicholls SJ, Navar AM, Chew DP, Kostner K, et al. Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia. Eur Cardiol. 2021;16:e54.
Lim S, Chung SH, Kim JH, Kim YH, Kim EJ, Joo HJ. Effects of metabolic parameters’ variability on cardiovascular outcomes in diabetic patients. Cardiovasc Diabetol. 2023;22(1):114.
Ghouth ASB. Prevalence and patterns of Dyslipidemia among Type2 Diabetes Mellitus patients in Mukalla City,Yemen, in 2017. J Community Med Public Health Care. 2019;6:048.
Hyassat D, Al-Saeksaek S, Naji D, Mahasneh A, Khader Y, Abujbara M, El-Khateeb M, Ajlouni K. Dyslipidemia among patients with type 2 diabetes in Jordan: prevalence, pattern, and associated factors. Front Public Health. 2022;10:1002466.
Ortega E, Amor AJ, Rojo-Martínez G, Castell C, Giménez M, Conget I. Enfermedad cardiovascular en pacientes con diabetes mellitus tipo 1 y tipo 2 en España [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain]. Med Clin (Barc). 2015;145(6):233–8.
Virani SS, Smith SC Jr, Stone NJ, Grundy SM. Secondary Prevention for Atherosclerotic Cardiovascular Disease: comparing recent US and European Guidelines on Dyslipidemia. Circulation. 2020;141(14):1121–3.
Mach F, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88.
Sun X, Du T. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988–2014. BMC Public Health. 2017;17(1):893.
Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, et al. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia. 2008;51(9):1581–93.
Heinsen LJ, Pararajasingam G, Andersen TR, Auscher S, Sheta HM, Precht H, et al. High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score. Cardiovasc Diabetol. 2021;20(1):164.
Scholte AJ, Schuijf JD, Kharagjitsingh AV, Jukema JW, Pundziute G, van der Wall EE, Bax JJ. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008;94(3):290–5.
Cheng VY, Wolak A, Gutstein A, Gransar H, Wong ND, Dey D, et al. Low-density lipoprotein and noncalcified coronary plaque composition in patients with newly diagnosed coronary artery disease on computed tomographic angiography. Am J Cardiol. 2010;105(6):761–6.
Hirai K, Kawasaki T, Soejima T, Kajiyama K, Fukami Y, Asada S, et al. Impact of intensive low-density lipoprotein cholesterol-lowering therapy on coronary artery plaques in Acute Coronary Syndrome. Am J Cardiol. 2023;204:84–91.
Goldberg IJ. Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–71.
Kim YG, Jeong JH, Han KD, Roh SY, Min K, Lee HS, Choi YY, Shim J, Choi JI, Kim YH. Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus. Cardiovasc Diabetol. 2023;22(1):36.
American Diabetes Association Professional Practice. 2. Classification and diagnosis of diabetes: standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38.
Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, et al. Committee of Public Relation of the Korean Society of Lipid and atherosclerosis. Dyslipidemia Fact Sheet in South Korea, 2022. J Lipid Atheroscler. 2023;12(3):237–51.
Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular surgery, American Heart Association. Circulation. 1975;51(4 Suppl):5–40.
Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, et al. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2016 Jul-Aug;10(4):269–81. CAD-RADS(TM) Coronary Artery Disease – Reporting and Data System.
Andreini D, Magnoni M, Conte E, Masson S, Mushtaq S, Berti S, et al. Coronary plaque features on CTA can identify patients at increased risk of Cardiovascular events. JACC Cardiovasc Imaging. 2020;13(8):1704–17.
Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54(1):49–57.
Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R, Alkadhi H. The napkin-ring sign: CT signature of high-risk coronary plaques? JACC Cardiovasc Imaging. 2010;3(4):440–4.
Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, ACC/AATS/AHA/, ASE/ASNC/SCAI/SCCT/STS et al. 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69(17):2212–2241.
Zhang HW, Jin JL, Cao YX, Guo YL, Wu NQ, Zhu CG, et al. Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovasc Diabetol. 2021;20(1):214.
Östgren CJ, Otten J, Festin K, Angerås O, Bergström G, Cederlund K, et al. Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study. Cardiovasc Diabetol. 2023;22(1):261.
Gao Y, Lu B, Sun ML, Hou ZH, Yu FF, Cao HL, et al. Comparison of atherosclerotic plaque by computed tomography angiography in patients with and without diabetes mellitus and with known or suspected coronary artery disease. Am J Cardiol. 2011;108(6):809–13.
Halon DA, Lavi I, Barnett-Griness O, Rubinshtein R, Zafrir B, Azencot M, et al. Plaque morphology as predictor of late plaque events in patients with asymptomatic type 2 diabetes: a long-term observational study. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1353–63.
Tanaka T, Kishi S, Ninomiya K, Ishizawa T, Kikushima H, Tomii D, et al. Clinical predictors of coronary artery plaque progression by quantitative serial Assessment using 320-Row computed Tomography Coronary Angiography in Asymptomatic patients with type 2 diabetes Mellitus. J Cardiol. 2020;76(4):378–84.
Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002;105(3):297–303.
Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30(7):1282–92.
Puchner SB, Mayrhofer T, Park J, Lu MT, Liu T, Maurovich-Horvat P, et al. Differences in the association of total versus local coronary artery calcium with acute coronary syndrome and culprit lesions in patients with acute chest pain: the coronary calcium paradox. Atherosclerosis. 2018Jul;274:251–7.
Puchner SB, Liu T, Mayrhofer T, Truong QA, Lee H, Fleg JL, et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol. 2014;64(7):684–92.
Otsuka K, Fukuda S, Tanaka A, Nakanishi K, Taguchi H, Yoshikawa J, et al. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc Imaging. 2013;6(4):448–57.
Deseive S, Straub R, Kupke M, Broersen A, Kitslaar PH, Stocker TJ, et al. Impact of diabetes on coronary artery plaque volume by coronary CT angiography and subsequent adverse cardiac events. J Cardiovasc Comput Tomogr. 2019 Jan-Feb;13(1):31–7.
Lusis AJ. Atherosclerosis Nat. 2000;407(6801):233–41.
Rodriguez V, Newman JD, Schwartzbard AZ. Towards more specific treatment for diabetic dyslipidemia. Curr Opin Lipidol. 2018;29(4):307–12.
Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes Ther. 2016;7(2):203–19.
Farmer JA. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Atheroscler Rep. 2007;9(2):162–8.
Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, et al. Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes. J Diabetes Res. 2015;2015:507245.
Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, et al. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes Mellitus. JACC Cardiovasc Imaging. 2016;9(11):1280–8.